ArticleFrontiers in pharmacology2021

Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients.

Sergio Ramirez-Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.